3 results
Approved WMOCompleted
To assess accuracy and reliability of new-to-market CGM systems in patients with type 1 diabetes.
Approved WMOCompleted
The aim of this study is to find out if a percutaneous angioplasty can be carried out safely in patients who received a therapeutic dose of Desirudin (Revasc®) before the operation.
Approved WMOCompleted
Primary ObjectivesThe primary objectives of the study are:· To determine the efficacy of Epanova 2 g daily compared to olive oil 2 g daily for 12 weeks in lowering serum TG levels in subjects with severehypertriglyceridemia (TG levels *500 mg/dL [5.…